tirzepatide compound going away / Niacinamide Injection Compounded GLP-1 - Semaglutide &
Description
This is not a long-term therapeutic dose
Patients with personal or family history of medullary thyroid carcinoma, Type 1 diabetes, diabetic ketoacidosis, or severe kidney disease should not use these medications
May 2023: Reaffirmed
Alexandra Sowa, click here to fill out an application
Therapeutic infusion coding with CPT 96365 requires the continuous intravenous delivery of a medication lasting longer than 15 minutes
Contact your PlexusDx provider if symptoms don't improve
